
As the COVID-19 pandemic continues to affect communities throughout the world, the search for effective drugs remains a priority. We’ve heard a lot about two potential treatments, hydroxychloroquine (HCQ) and remdesivir (RDV), both of which are being tested in clinical trials. But what do we know about these compounds and how well they work?
Forbes
No comments:
Post a Comment